TickerFacts.

Meihua International Medical Technologies Co., Ltd. (MHUAF): Revenue

Annual figures by period end, from SEC filings.

$61.79M
Year ended 2025-12-31
-15.8%
3-year compound annual growth
-7.1%
5-year compound annual growth
$104.04M2019-12-31: $79.63M2020-12-31: $89.06M2021-12-31: $104.04M2022-12-31: $103.35M2023-12-31: $97.10M2024-12-31: $96.91M2025-12-31: $61.79M$61.79M
2019-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$61.79M-36.2%2026-04-29, From 2025-01-01
2024-12-31$96.91M-0.2%2026-04-29, From 2024-01-01
2023-12-31$97.10M-6.0%2026-04-29, From 2023-01-01
2022-12-31$103.35M-0.7%2023-08-29, From 2022-01-01
2021-12-31$104.04M+16.8%2023-08-29, From 2021-01-01
2020-12-31$89.06M+11.8%2023-08-29, From 2020-01-01
2019-12-31$79.63Mn/a2022-07-29, From 2019-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$61.79M-36.2%
LENSAR, Inc. (LNSR)2025-12-31$58.44M+9.2%
CVRx, Inc. (CVRX)2025-12-31$56.65M+10.4%
AVITA Medical, Inc. (RCEL)2025-12-31$71.61M+11.5%
Apyx Medical Corp (APYX)2025-12-31$52.84M+9.9%
Carlsmed, Inc. (CARL)2025-12-31$50.51M+85.9%
Sight Sciences, Inc. (SGHT)2025-12-31$77.36M-3.1%
PRO DEX Inc (PDEX)2026-06-30$77.55M+16.5%
TELA Bio, Inc. (TELA)2025-12-31$80.28M+15.8%

Compare MHUAF, LNSR, CVRX, RCEL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗